Oral bisphosphonates and oesophageal cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.BMJ open · 2015
   Pooled it
2. Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004-2023).Frontiers in pharmacology · 2024
   Article
3. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
   Article
4. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.The American journal of gastroenterology · 2013
   Article
5. Mechanisms of bone anabolism regulated by statins.Bioscience reports · 2012
   Review
6. Pharmacovigilance.British journal of clinical pharmacology · 2012
   Article
7. A reappraisal of generic bisphosphonates in osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
   Review
8. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).PloS one · 2012
   Article
9. Safety of drugs used in the treatment of osteoporosis.Therapeutic advances in drug safety · 2011
   Review

Corrections and comments

• Comment on
  Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as